Search Results

You are looking at 41 - 50 of 151 items for :

  • "renal cell carcinoma" x
Clear All
Full access

Robert W. Carlson and Eric Jonasch

, Professor of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, and Vice Chair of the NCCN Kidney Cancer Panel, who described how this tool can be used in managing metastatic renal cell carcinoma (RCC). Evidence

Full access

Christopher E. Desch

, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor in patients with metastatic renal cell carcinoma . J Clin Oncol 2006 ; 24 : 16 – 24 . 2. Pfizer Oncology. Sutent

Full access

Sriman Swarup, Anita Sultan, Nusrat Jahan, Upama Sharma, Nimesh Adhikari, Yin M. Myat, Ye Aung, Myo H. Zaw and Kyaw Z. Thein

,703 patients with medullary thyroid cancer, prostate cancer, renal cell carcinoma, and hepatocellular carcinoma were eligible. Studies comparing cabozantinib (C) vs everolimus, C vs placebo, C vs prednisone were included in the analysis. The relative risks of

Full access

The UNMC Eppley Cancer Center at The Nebraska Medical Center

An estimated 38,890 Americans will be diagnosed with kidney cancer and 12,840 will die of this disease in the United States in 2006. Renal cell carcinoma (RCC) constitutes approximately 2% of all malignancies, with a median age at diagnosis of 65 years. Smoking and obesity are among the risk factors for RCC development, and tumor grade, local extent of the tumor, presence of regional nodal metastases, and evidence of metastatic disease at presentation are the most important prognostic determinants of 5-year survival. These guidelines discuss evaluation, staging, treatment, and management after treatment.

For the most recent version of the guidelines, please visit NCCN.org

Full access

Patricia Thompson and Mayer Fishman

. Immunotherapy of metastatic renal cell cancer . Review . Cancer Control 2002 ; 9 : 293 – 304 . 3 Motzer RJ Bander NH Nanus DM . Renal-cell carcinoma . N Engl J Med 1996 ; 335 : 865 – 875 . 4 Motzer RJ Mazumdar M Bacik J . Survival

Full access

Ralph Hauke

://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf . Accessed September 12, 2006 . 2. Chow WH Devesa SS Warren JL Fraumeni JF Jr . Rising incidence of renal cell carcinoma in the United States . JAMA 1999 ; 281 : 1628 – 1631 . 3. Hock LM Lynch J Balaji KC

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Kanishka Sircar, Brad Somer, Jue Wang, Richard B. Wilder, Mary A. Dwyer and Rashmi Kumar

estimated 63,920 Americans will be diagnosed with renal cancer and 13,860 will die of the disease in the United States in 2014. 1 Renal cell carcinoma (RCC) comprises approximately 3.9% of new cancers, with a median age at diagnosis of 64 years. The rate of

Full access

9 9 Suppl_1 Suppl_1 NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy Hudes Gary R. MD Carducci Michael A. MD Choueiri Toni K. MD Esper Peg MSN, MSA, RN, ANP-BC, AOCN Jonasch Eric MD Kumar

Full access

Rodger J. Winn

costs and length of stay for radical nephrectomy versus nephron-spring surgery in the management of localized renal cell carcinoma . Urology 1999 ; 54 : 994 - 998 . 3 Clark PE Schover LR Uzzo RG . Quality of life and psychological

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey Sosman, Mary Dwyer and Rashmi Kumar

estimated 62,700 Americans were diagnosed with renal cancer and 14,240 died of the disease in 2016. 1 Renal cell carcinoma (RCC) constitutes approximately 3.8% of all new cancers, with a median age at diagnosis of 64 years. Approximately 90% of renal tumors